Not finding it? Sign in to also search OpenAlex live.
-
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn2024 New England Journal of Medicine article Medicine Blood groups and transfusion cited by 1 patent
Kenneth Joseph Moise, Leona E. Ling, Dick Oepkes, Eleonor Tiblad, E. J. T. Verweij, Enrico Lopriore, +22 more
112citations -
OC07.03: Nipocalimab pharmacodynamics in a phase 2 study in pregnancies at risk of early‐onset severe hemolytic disease of the fetus and newborn2023 Ultrasound in Obstetrics and Gynecology conference-abstract Medicine Blood groups and transfusion cited by 2 patents
L. E. Ling, Jocelyn H. Leu, Masja de Haas, May Lee Tjoa, Shumyla Saeed-Khawaja, Eleonor Tiblad, +4 more
0citations -
Comparison of intrauterine transfusion techniques in hemolytic disease of the fetus and newborn2025 Ultrasound in Obstetrics and Gynecology article Medicine Blood groups and transfusion Open access
Renske Marijke van 't Oever, Femke Slaghekke, Monique C. Haak, Derek P. de Winter, Enrico Lopriore, Masja de Haas, +2 more
5citations -
Long-term neurodevelopmental outcomes after intrauterine transfusion for alloimmune hemolytic disease of the fetus and newborn2025 Best Practice & Research Clinical Obstetrics & Gynaecology article Medicine Blood groups and transfusion Open access
Jeanine M.M. van Klink, Derek P. de Winter, Renske Marijke van 't Oever, Ratna N.G.B. Tan, Joanne E.J.T. Verweij, Masja de Haas, +1 more
1citations -
Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions2020 American Journal of Obstetrics and Gynecology article Medicine Blood groups and transfusion Open access
Isabelle M. C. Ree, Enrico Lopriore, Carolien Zwiers, Stefan Böhringer, Marleen Janssen, Dick Oepkes, +1 more
41citations -
Monitoring and management of hemolytic disease of the fetus and newborn based on an international expert Delphi consensus2024 American Journal of Obstetrics and Gynecology article Medicine Blood groups and transfusion Open access
Hiba J. Mustafa, Enaja V. Sambatur, Alireza Abdollah Shamshirsaz, Sonia Johnson, Kenneth Joseph Moise, Ahmet Baschat, +14 more
24citations -
Reduction of anti‐K‐mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation‐wide policy change evaluation study in the Netherlands
Jessie S. Luken, Claudia C. Folman, Michaël V. Lukens, Johan H. Meekers, Peter C. Ligthart, Henk Schonewille, +5 more
23citations -
Factor B Inhibition with Oral Iptacopan Monotherapy Demonstrates Sustained Long-Term Efficacy and Safety in Anti-C5-Treated Patients (pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia: Final 48-Week Results from the Multicenter, Phase III APPLY-PNH Trial
Antonio Maria Risitano, Austin Gladston Kulasekararaj, Alexander Roeth, Phillip Scheinberg, Yutaka Ueda, Eros Di Bona, +29 more
14citations -
S182: ORAL IPTACOPAN MONOTHERAPY INCREASES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) RED BLOOD CELL CLONE SIZE VIA CONTROL OF INTRA- AND EXTRAVASCULAR HEMOLYSIS IN ANTI-C5-TREATED PNH PATIENTS WITH ANEMIA
Antonio Maria Risitano, Alexander Röth, Austin Gladston Kulasekararaj, Phillip Scheinberg, Yutaka Ueda, Eros Di Bona, +28 more
2citations